VERA earnings date and last-quarter result: last quarter miss, P/E -6.51. Updated 2026-07-23.
Vera Therapeutics (VERA) Research Hub
Vera Therapeutics (VERA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 28.3 USD (+1.11%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.51, market cap 2.60B. This hub links to the full technical, earnings and options research available for VERA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 28.3 USD (+1.11%) |
| 52-week range | 26.45 USD – 44.87 USD |
| Trend regime | Range |
| 14-day RSI | 46 (Neutral) |
| Trailing P/E | -6.51 |
| Market cap | 2.60B |
| Dividend yield | 0.00% |
Available research for VERA
Covered Call on VERA: how it works, illustrative setup around the real 28.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VERA: how it works, illustrative setup around the real 28.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VERA: how it works, illustrative setup around the real 28.3 USD price, max profit/loss, breakeven and when to use it. Educational.
VERA technical analysis: range, last 28.3 USD, RSI 46, 52w range 26.45 USD–44.87 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VERA in?
Vera Therapeutics (VERA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VERA in an uptrend or downtrend?
As of 2026-10-26, VERA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VERA's trailing P/E ratio?
VERA's trailing P/E is -6.51, with a market cap of 2.60B. See the earnings research page for full valuation detail.